Elekta (OTCMKTS:EKTAY) Issues Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) announced its quarterly earnings results on Thursday. The company reported $0.07 EPS for the quarter, Zacks reports. Elekta had a negative net margin of 2.38% and a positive return on equity of 13.31%. The firm had revenue of $372.30 million during the quarter.

Elekta Stock Performance

OTCMKTS:EKTAY opened at $5.63 on Friday. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47. Elekta has a 1-year low of $4.35 and a 1-year high of $6.93. The stock’s 50-day moving average is $5.20 and its 200-day moving average is $5.70. The stock has a market cap of $2.08 billion, a P/E ratio of -46.91 and a beta of 1.01.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Elekta currently has a consensus rating of “Reduce”.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.